Get Moxibustion Insights First
Sign up for moxibustion techniques, wellness tips and industry news delivered to your inbox.
Is Moxibustion Safe During Pregnancy? Evidence & BL67 Exception
Is moxibustion safe during pregnancy?
Moxibustion is not safe on the lower abdomen, sacrum, or any point that could stimulate uterine contractions throughout pregnancy. However, a single, well‑researched exception exists: moxibustion at the acupoint BL67 on the little toe to turn a breech baby between 33 and 35 weeks of gestation.
Pregnancy fundamentally alters a woman’s heat sensitivity, skin condition, and uterine stability. The standard rule is to avoid all heat applications over the trunk and pelvis unless a clear therapeutic need exists and is supervised by a qualified midwife or obstetrician. The BL67 protocol is the only pregnancy‑specific moxibustion application supported by systematic review evidence. For a comprehensive safety framework, see our moxibustion safety hub. For a list of all absolute contraindications, refer to contraindications explained.
Which body areas are strictly off‑limits during pregnancy?
The entire lower abdomen and sacral region are contraindicated. This includes CV3, CV4, CV6, and sacral points such as BL27–BL34. Heat over these areas can theoretically provoke uterine contractions, especially in the third trimester, and may increase the risk of preterm labour.
Even distal points that historically are used to move qi vigorously—such as SP6 (Sanyinjiao)—are avoided during pregnancy unless under strict clinical protocols, because they may stimulate cervical ripening near term. Practitioners apply moxa only to points that have been proven safe in pregnancy trials, and the short list is essentially limited to BL67 for breech correction and, in some protocols, ST36 for general health support away from the abdomen. For guidance on safe point selection, visit our moxibustion techniques page.
Why is BL67 the only acupoint used during pregnancy?
BL67 (Zhiyin), located on the outer corner of the little toe, is far from the uterus and does not influence the pelvis or cervix thermally. Multiple randomised controlled trials have shown that stimulating BL67 with a moxa stick between 33 and 35 weeks significantly increases the rate of cephalic version without increasing adverse events.
The point sits at the endpoint of the bladder meridian, which in TCM theory relates to the uterus via an internal connection. Modern research suggests that the warmth and stimulation of BL67 increase fetal movement and alter maternal prostaglandin and cortisol levels, promoting spontaneous turning. For a detailed step‑by‑step protocol, see our article on moxibustion for breech presentation.
What does the evidence say about the safety of moxibustion at BL67?
The 2023 Cochrane review evaluated moxibustion at BL67 and reported that no increase in adverse maternal or fetal outcomes was detected in the included trials. The safety profile is considered favourable, with minor burns and mild smoke irritation being the only documented side effects when the procedure is performed correctly.
Cochrane safety summary: Across multiple RCTs, moxibustion at BL67 showed no significant difference in miscarriage, preterm birth, or neonatal complications compared to usual care. The evidence certainty for safety is moderate, consistent with the evidence for efficacy [1].
Nonetheless, all trials involved supervision by a midwife or obstetrician who confirmed the fetal position via ultrasound before and after the treatment period. Safety cannot be extrapolated to unsupervised home use without initial instruction and monitoring. For background on general adverse events with moxibustion, see our review of moxibustion side effects & risks.
What extra precautions must be taken during pregnancy moxibustion?
Treatment must only occur after ultrasound confirmation of a single breech pregnancy, between 33 and 35 weeks. The mother should be seated or reclining comfortably, with the moxa stick held 2–3 cm from BL67. Adequate ventilation is essential to avoid smoke accumulation, and the skin must be checked frequently.
Contraindications to BL67 moxibustion include placenta praevia, a history of preterm labour, multiple pregnancy, or any vaginal bleeding. Never apply moxibustion to BL67 before 33 weeks—when many breech presentations resolve spontaneously—or after 36 weeks, when the fetus may be too large to turn. Fetal movements must be monitored daily, and a reduction in movement requires immediate obstetric review [1].
Regular communication with the lead maternity carer is non‑negotiable. The partner or the woman herself can be taught the technique by a qualified professional, but ongoing oversight remains crucial. For safe home practice in general, consult our home moxibustion guide.
How should midwives and obstetricians be involved?
The midwife or obstetrician must confirm the breech presentation via ultrasound before starting moxibustion and verify fetal well‑being. They coordinate with the acupuncturist or moxibustion practitioner to set a clear timeline, typically 1–2 weeks of daily treatment, with a planned follow‑up ultrasound to assess the outcome.
A multidisciplinary approach ensures that if moxibustion is unsuccessful, external cephalic version or elective caesarean section can be arranged without delay. No complementary therapy should ever replace standard antenatal care. For more about integrating moxibustion into a wider care plan, see our moxibustion benefits overview.
At a glance: Moxibustion during pregnancy – safety rules
| Aspect | Recommendation |
|---|---|
| Abdomen & sacrum | Never apply moxibustion during pregnancy |
| BL67 (little toe) | Only safe point for breech, 33–35 weeks |
| Contraindications | Placenta praevia, preterm labour history, multiple pregnancy, bleeding |
| Supervision | Midwife or obstetrician must confirm position and monitor |
| Technique | Indirect moxa stick, 2–3 cm distance, 15–20 min per foot |
| Adverse events | Minor burns, smoke irritation; rare serious events |
| Evidence quality | Moderate certainty (Cochrane GRADE) |
Continue Reading
References
- Coyle ME, Smith C, Peat B. Cephalic version by moxibustion for breech presentation. Cochrane Database Syst Rev. 2023 May 9. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003928.pub4/information
- Xu J, et al. Safety of Moxibustion: A Systematic Review of Case Reports. Evid Based Complement Alternat Med. 2014;2014:783704. https://pmc.ncbi.nlm.nih.gov/articles/PMC4058265/
Disclaimer: This content is provided for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Moxibustion during pregnancy must only be performed under the direct supervision of a qualified healthcare professional. Always consult your midwife, obstetrician, or doctor before considering any complementary therapy during pregnancy. The safety information presented here reflects current evidence and may evolve with further research.
Don't miss out any moxibustion tips!
Stay tuned for all of our weekly helpful updates!